Haleon PLC (HLN) - Net Assets
Based on the latest financial reports, Haleon PLC (HLN) has net assets worth GBX16.00 Billion GBX (≈ $1.95 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX31.83 Billion ≈ $3.87 Million USD) and total liabilities (GBX15.83 Billion ≈ $1.93 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Haleon PLC (HLN) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX16.00 Billion |
| % of Total Assets | 50.26% |
| Annual Growth Rate | -9.95% |
| 5-Year Change | -38.13% |
| 10-Year Change | N/A |
| Growth Volatility | 14.84 |
Haleon PLC - Net Assets Trend (2019–2024)
This chart illustrates how Haleon PLC's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of Haleon PLC to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Haleon PLC (2019–2024)
The table below shows the annual net assets of Haleon PLC from 2019 to 2024. For live valuation and market cap data, see Haleon PLC market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | GBX16.22 Billion ≈ $1.97 Million |
-3.02% |
| 2023-12-31 | GBX16.73 Billion ≈ $2.04 Million |
+1.65% |
| 2022-12-31 | GBX16.46 Billion ≈ $2.00 Million |
-37.85% |
| 2021-12-31 | GBX26.48 Billion ≈ $3.22 Million |
+0.98% |
| 2020-12-31 | GBX26.22 Billion ≈ $3.19 Million |
-4.34% |
| 2019-12-31 | GBX27.41 Billion ≈ $3.34 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Haleon PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 434.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | GBX27.27 Billion | 168.70% |
| Common Stock | GBX91.00 Million | 0.56% |
| Other Comprehensive Income | GBX-11.08 Billion | -68.55% |
| Total Equity | GBX16.17 Billion | 100.00% |
Haleon PLC Competitors by Market Cap
The table below lists competitors of Haleon PLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Reckitt Benckiser Group PLC
LSE:RKT
|
$361.40 Million |
|
Shandong Minhe Animal Husbandry Co Ltd
SHE:002234
|
$361.53 Million |
|
Hotel Majestic Cannes
PA:MLHMC
|
$361.67 Million |
|
Lontrue Co Ltd
SHE:300175
|
$361.69 Million |
|
Viking Line Abp
HE:VIK1V
|
$361.15 Million |
|
Southern States Bancshares Inc
NASDAQ:SSBK
|
$361.07 Million |
|
Shandong Sinobioway Biomedicine Co Ltd
SHE:002581
|
$361.06 Million |
|
HPF Co Ltd
SHE:300350
|
$361.03 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Haleon PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 16,606,000,000 to 16,166,000,000, a change of -440,000,000 (-2.6%).
- Net income of 1,442,000,000 contributed positively to equity growth.
- Dividend payments of 570,000,000 reduced retained earnings.
- Share repurchases of 619,000,000 reduced equity.
- Other comprehensive income decreased equity by 121,000,000.
- Other factors decreased equity by 572,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX1.44 Billion | +8.92% |
| Dividends Paid | GBX570.00 Million | -3.53% |
| Share Repurchases | GBX619.00 Million | -3.83% |
| Other Comprehensive Income | GBX-121.00 Million | -0.75% |
| Other Changes | GBX-572.00 Million | -3.54% |
| Total Change | GBX- | -2.65% |
Book Value vs Market Value Analysis
This analysis compares Haleon PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 189.16x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 112.66x to 189.16x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | GBX2.96 | GBX333.30 | x |
| 2020-12-31 | GBX2.83 | GBX333.30 | x |
| 2021-12-31 | GBX2.85 | GBX333.30 | x |
| 2022-12-31 | GBX1.77 | GBX333.30 | x |
| 2023-12-31 | GBX1.79 | GBX333.30 | x |
| 2024-12-31 | GBX1.76 | GBX333.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Haleon PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.92%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 12.84%
- • Asset Turnover: 0.33x
- • Equity Multiplier: 2.12x
- Recent ROE (8.92%) is above the historical average (5.63%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 2.40% | 7.72% | 0.24x | 1.31x | GBX-2.08 Billion |
| 2020 | 4.38% | 11.58% | 0.29x | 1.31x | GBX-1.47 Billion |
| 2021 | 5.27% | 14.56% | 0.28x | 1.31x | GBX-1.25 Billion |
| 2022 | 6.49% | 9.76% | 0.31x | 2.13x | GBX-573.10 Million |
| 2023 | 6.32% | 9.28% | 0.33x | 2.05x | GBX-611.60 Million |
| 2024 | 8.92% | 12.84% | 0.33x | 2.12x | GBX-174.60 Million |
Industry Comparison
This section compares Haleon PLC's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $269,947,271
- Average return on equity (ROE) among peers: -72.29%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Haleon PLC (HLN) | GBX16.00 Billion | 2.40% | 0.99x | $361.16 Million |
| Allergy Therapeutics (AGY) | $20.08 Million | -10.91% | 0.33x | $5.60 Million |
| Animalcare Group Plc (ANCR) | $3.80 Million | 0.00% | 0.57x | $2.78 Million |
| Alliance Pharma plc (APH) | $70.78 Million | 11.85% | 0.52x | $4.26 Million |
| Celadon Pharmaceuticals PLC (CEL) | $3.18 Million | -224.46% | 1.90x | $112.25K |
| Chill Brands Group PLC (CHLL) | $878.67K | -488.00% | 5.99x | $174.97K |
| Eco Animal Health Group Plc (EAH) | $58.25 Million | 3.81% | 0.20x | $750.93K |
| HUTCHMED China Ltd (HCM) | $1.25 Billion | 36.57% | 0.40x | $16.32 Million |
| Hikma Pharmaceuticals PLC (HIK) | $1.03 Billion | 20.50% | 0.87x | $39.53 Million |
| Indivior PLC (INDV) | $-11.00 Million | 0.00% | 0.00x | $18.79 Million |
About Haleon PLC
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene… Read more